[{"id":"ef445441-1fa2-4ae0-902f-a212eb32e07a","acronym":"","url":"https://clinicaltrials.gov/study/NCT05150405","created_at":"2021-12-09T18:00:08.188Z","updated_at":"2024-07-02T16:35:22.471Z","phase":"Phase 1","brief_title":"A Phase Ia Clinical Study of QLF31907 Injection in Patients With Advanced Malignant Tumors","source_id_and_acronym":"NCT05150405","lead_sponsor":"Qilu Pharmaceutical Co., Ltd.","biomarkers":" MSI","pipe":" | ","alterations":" MSI-H/dMMR","tags":["MSI"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e MSI-H/dMMR"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e QL301"],"overall_status":"Recruiting","enrollment":" Enrollment 54","initiation":"Initiation: 10/19/2021","start_date":" 10/19/2021","primary_txt":" Primary completion: 03/31/2024","primary_completion_date":" 03/31/2024","study_txt":" Completion: 06/01/2024","study_completion_date":" 06/01/2024","last_update_posted":"2024-01-23"}]